Erik Munson

2.0k total citations
114 papers, 1.4k citations indexed

About

Erik Munson is a scholar working on Microbiology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Erik Munson has authored 114 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Microbiology, 39 papers in Epidemiology and 37 papers in Infectious Diseases. Recurrent topics in Erik Munson's work include Bacterial Identification and Susceptibility Testing (33 papers), Reproductive tract infections research (31 papers) and Vector-borne infectious diseases (14 papers). Erik Munson is often cited by papers focused on Bacterial Identification and Susceptibility Testing (33 papers), Reproductive tract infections research (31 papers) and Vector-borne infectious diseases (14 papers). Erik Munson collaborates with scholars based in United States, Canada and United Kingdom. Erik Munson's co-authors include Gary V. Doern, Daniel J. Diekema, Susan E. Beekmann, Kimberle C. Chapin, Ronald F. Schell, Karen C. Carroll, Steven M. Callister, Brian Bennett, Chieu D. Tran and Timothy M. Block and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and CHEST Journal.

In The Last Decade

Erik Munson

108 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik Munson United States	17	454	436	358	356	317	114	1.4k
Vicky Cevallos United States	24	576 1.3×	135 0.3×	570 1.6×	517 1.5×	269 0.8×	50	2.1k
Joel E. Mortensen United States	26	650 1.4×	211 0.5×	272 0.8×	414 1.2×	525 1.7×	107	1.9k
Marion J. Tuohy United States	23	757 1.7×	319 0.7×	183 0.5×	264 0.7×	594 1.9×	52	1.7k
Christian Theilacker Germany	27	665 1.5×	283 0.6×	362 1.0×	255 0.7×	785 2.5×	73	2.1k
Steen Hoffmann Denmark	27	721 1.6×	155 0.4×	704 2.0×	656 1.8×	551 1.7×	90	1.9k
Felicia Ruffin United States	22	448 1.0×	447 1.0×	280 0.8×	66 0.2×	692 2.2×	71	1.4k
Julie Pearson Australia	25	356 0.8×	704 1.6×	348 1.0×	99 0.3×	1.2k 3.9×	64	1.7k
Hagen Frickmann Germany	24	526 1.2×	261 0.6×	435 1.2×	115 0.3×	936 3.0×	227	2.5k
Greg B. Horsman Canada	26	609 1.3×	197 0.5×	261 0.7×	626 1.8×	522 1.6×	65	1.7k
Clare Ling United Kingdom	19	334 0.7×	124 0.3×	413 1.2×	112 0.3×	268 0.8×	53	1.2k

Countries citing papers authored by Erik Munson

Since Specialization

Citations

This map shows the geographic impact of Erik Munson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Munson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Munson more than expected).

Fields of papers citing papers by Erik Munson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Munson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Munson. The network helps show where Erik Munson may publish in the future.

Co-authorship network of co-authors of Erik Munson

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Munson. A scholar is included among the top collaborators of Erik Munson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Munson. Erik Munson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bobenchik, April M., Robin R. Chamberland, Andrew E. Clark, et al.. (2025). Activity of novel ceftibuten-avibactam, ceftazidime-avibactam, and comparators against a challenge set of Enterobacterales from outpatient centers and nursing homes across the United States (2022–2024). Antimicrobial Agents and Chemotherapy. 69(5). e0186724–e0186724. 1 indexed citations

Carroll, Karen C., et al.. (2025). An update on novel taxa and revised taxonomic status of bacteria isolated from human clinical specimens described in 2024. Journal of Clinical Microbiology. 63(12). e0106825–e0106825.

Burbick, Claire R., et al.. (2025). Update on novel, validly published, and included bacterial taxa derived from nondomestic animals and taxonomic revisions published in 2024. Journal of Clinical Microbiology. 64(1). e0107025–e0107025. 1 indexed citations

Ryan, Daniel T., et al.. (2024). Asymptomatic Rectal Bacterial Pathogens Show Large Prospective Relationships With HIV Incidence in a Cohort of Young Sexual and Gender Minorities: Implications for STI Screening and HIV Prevention. Open Forum Infectious Diseases. 11(8). ofae444–ofae444. 1 indexed citations

Stafford, Irene, et al.. (2024). 333 A molecular diagnostic assay for syphilis infection among a high-risk pregnant cohort.. American Journal of Obstetrics and Gynecology. 230(1). S189–S189.

Asempa, Tomefa E., April M. Bobenchik, Lori Bourassa, et al.. (2023). Antimicrobial Activity of Tebipenem and Comparators against Enterobacterales from diverse Outpatient Centers and Nursing Homes in the United States. International Journal of Antimicrobial Agents. 61(3). 106733–106733. 5 indexed citations

Munson, Erik, et al.. (2022). Changes inStreptococcus pneumoniaeSusceptibility in Wisconsin: Implications for Clinical Treatment Decisions for Respiratory Infections. Clinical Medicine & Research. 20(4). 185–194. 1 indexed citations

Fox, Barry, et al.. (2022). Surveillance of Fluoroquinolone Resistance in Wisconsin: Geographic Variation and Impact of Revised CLSI Breakpoints. Clinical Medicine & Research. 20(2). 81–88. 1 indexed citations

Stafford, Irene, K Hummel, James J. Dunn, et al.. (2021). Retrospective analysis of infection and antimicrobial resistance patterns of Mycoplasma genitalium among pregnant women in the southwestern USA. BMJ Open. 11(6). e050475–e050475. 14 indexed citations

10.

Munson, Erik, et al.. (2021). Surveillance of Wisconsin Organisms for Trends in Antimicrobial Resistance and Epidemiology (SWOTARE): 2018-2019 Report on Enterobacter cloacae and Klebsiella pneumoniae Clinical Isolates. Clinical Medicine & Research. 19(3). 123–131. 6 indexed citations

11.

Munson, Erik, et al.. (2019). Staphylococcus aureus Resistance Patterns in Wisconsin. Clinical Medicine & Research. 17(3-4). 72–81. 15 indexed citations

12.

Munson, Erik, et al.. (2018). Surveillance of Wisconsin Organisms for Trends in Antimicrobial Resistance and Epidemiology: Introduction to the Program and Summary of 2016 Geographic Variation.. PubMed. 117(3). 116–121. 8 indexed citations

13.

Tran, Chieu D., et al.. (2017). Biocompatible Copper Oxide Nanoparticle Composites from Cellulose and Chitosan: Facile Synthesis, Unique Structure, and Antimicrobial Activity. ACS Applied Materials & Interfaces. 9(49). 42503–42515. 77 indexed citations

14.

Munson, Erik, et al.. (2017). Determination of MIC and disk diffusion quality control guidelines for meropenem–vaborbactam, a novel carbapenem/boronic acid β-lactamase inhibitor combination. Diagnostic Microbiology and Infectious Disease. 90(4). 324–328. 9 indexed citations

15.

Kuo, Joseph, Thomas F. Warner, Erik Munson, Dean T. Nardelli, & Ronald F. Schell. (2016). Arthritis is developed inBorrelia-primed and -infected mice deficient of interleukin-17. Pathogens and Disease. 74(7). ftw077–ftw077. 5 indexed citations

16.

Munson, Erik, et al.. (2013). Impact of toxigenic Clostridium difficile polymerase chain reaction testing on the clinical microbiology laboratory and inpatient epidemiology. Diagnostic Microbiology and Infectious Disease. 76(4). 534–538. 7 indexed citations

17.

Munson, Erik, et al.. (2013). Insights into trichomoniasis as a result of highly sensitive molecular diagnostics screening in a high-prevalence sexually transmitted infection community. Expert Review of Anti-infective Therapy. 11(8). 845–863. 8 indexed citations

18.

Munson, Erik, et al.. (2011). Clinical laboratory evaluation of Invader® chemistry and hybrid capture for detection of high-risk human papillomavirus in liquid-based cytology specimens. Diagnostic Microbiology and Infectious Disease. 71(3). 230–235. 5 indexed citations

19.

Munson, Erik, et al.. (2010). Trichomonas vaginalis transcription-mediated amplification-based analyte-specific reagent and alternative target testing of primary clinical vaginal saline suspensions. Diagnostic Microbiology and Infectious Disease. 68(1). 66–72. 13 indexed citations

20.

Munson, Erik, Michael A. Pfaller, Franklin P. Koontz, & Gary V. Doern. (2002). Comparison of Porphyrin-Based, Growth Factor-Based, and Biochemical-Based Testing Methods for Identification of Haemophilus influenzae. European Journal of Clinical Microbiology & Infectious Diseases. 21(3). 196–203. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact